Cargando…
COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the complicated disease COVID-19. Clinicians are continuously facing huge problems in the treatment of patients, as COVID-19-specific drugs are not available, hence the principle of drug repurposing serves as a one-and-only hope. Gl...
Autores principales: | Kumar, Sunny, Basu, Malini, Ghosh, Pratyasha, Pal, Uttam, Ghosh, Mrinal K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079314/ https://www.ncbi.nlm.nih.gov/pubmed/37334160 http://dx.doi.org/10.1016/j.gendis.2022.12.019 |
Ejemplares similares
-
Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
por: Kumar, Sunny, et al.
Publicado: (2022) -
Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions
por: Sarkar, Sibani, et al.
Publicado: (2023) -
Chaperone-assisted E3 ligase CHIP: A double agent in cancer
por: Kumar, Sunny, et al.
Publicado: (2021) -
Drug repurposing: An effective strategy to accelerate contemporary drug discovery
por: Zhan, Peng, et al.
Publicado: (2022) -
Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19
por: Das, Gourab, et al.
Publicado: (2021)